1. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion
   Yining Zhang et al, 2023, International Immunopharmacology CrossRef
2. Deep Learning Approaches to Osteosarcoma Diagnosis and Classification: A Comparative Methodological Approach
   Ioannis A. Vezakis et al, 2023, Cancers CrossRef
3. Mechanisms of multidrug resistance in cancer
   Fatemeh Zahedipour et al, 2023, Aptamers Engineered Nanocarriers for Cancer Therapy CrossRef
4. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer
   Ruikai Du et al, 2018, Cell Death & Disease CrossRef
5. DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma
   Forough Alemi et al, 2022, Journal of Cellular Physiology CrossRef
6. Melatonin upregulates DNA-PKcs to suppress apoptosis of human umbilical vein endothelial cells via inhibiting miR-101 under H2O2-induced oxidative stress
   Hao Gu et al, 2021, Molecular and Cellular Biochemistry CrossRef
7. Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
   Zeting Yuan et al, 2020, British Journal of Cancer CrossRef
8. Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer
   Yanguang Li et al, 2021, Archives of Biochemistry and Biophysics CrossRef
9. The molecular mechanisms of chemoresistance in cancers
   Hua-Chuan Zheng, 2017, Oncotarget CrossRef
10. The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
    Liang Xu et al, 2020, Journal of Bone Oncology CrossRef
11. Epigenetic regulation of cancer stem cells: Shedding light on the refractory/relapsed cancers
    Libo Xu et al, 2022, Biochemical Pharmacology CrossRef
12. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma
    Gen-Tao Fan et al, 2021, Biochemical and Biophysical Research Communications CrossRef
13. Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63
    Xiong Shu et al, 2021, PeerJ CrossRef
14. Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
    Massimo Serra et al, 2021, Cells CrossRef
15. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel
    Marjan Aghajani et al, 2020, Molecular Biology Reports CrossRef
16. Polydatin enhances the chemosensitivity of osteosarcoma cells to paclitaxel
    Weijia Zhao et al, 2019, Journal of Cellular Biochemistry CrossRef
17. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells
    Xue Li et al, 2021, Journal of Pharmacy and Pharmacology CrossRef
18. Polydatin: A natural compound with multifaceted anticancer properties
    Khalid Imtiyaz et al, 2024, Journal of Traditional and Complementary Medicine CrossRef
19. Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters
    Sara R. Martins-Neves et al, 2022, International Journal of Molecular Sciences CrossRef